Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway

Abstract Drug resistance is a crucial obstacle to achieve satisfactory chemotherapeutic effects. Numerous studies have shown that the PI3K/Akt signaling pathway plays a significant role in various processes of cellular events and tumor progression, while few studies have focused on the PI3K/Akt sign...

Full description

Bibliographic Details
Main Authors: Rong Zhang, Limin Huang, Di Pan, Wen Zhang
Format: Article
Language:English
Published: Universidade de São Paulo 2022-09-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100700&tlng=en
_version_ 1811266380165545984
author Rong Zhang
Limin Huang
Di Pan
Wen Zhang
author_facet Rong Zhang
Limin Huang
Di Pan
Wen Zhang
author_sort Rong Zhang
collection DOAJ
description Abstract Drug resistance is a crucial obstacle to achieve satisfactory chemotherapeutic effects. Numerous studies have shown that the PI3K/Akt signaling pathway plays a significant role in various processes of cellular events and tumor progression, while few studies have focused on the PI3K/Akt signaling pathway in drug resistance of endothelial cells. The present study aims to explore the relationship of PI3K/Akt signaling and cellular resistance to anticancer drugs in human microvessel endothelial cells (HMEC-1). We established stable sunitinib-resiatant human microvessel endothelial cells (HMEC-su) after long-term exposure to sunitinib (a small-molecule tyrosine kinase receptor inhibitor) for 12 months. HMEC-su showed significant alternations of cell morphology and exhibited a 2.32-fold higher IC50 of sunitinib than parental HMEC-1 cells. Expression of P-glycoprotein (P-gp) and breast cancer-resistance protein (ABCG2) which mediates drug efflux, increased significantly in HMEC-su lines compared with HMEC-1 cells by western blots assay. Our study further demonstrates that LY294002 (blocking the PI3K/Akt pathway) enhances the sensibility of HMEC-su to suntinib and inhibits the gene transcription and protein expression of P-gp, ABCG2 in HMEC-su cells. In conclusion, these results indicate that LY294002 could reverse P-gp and ABCG2 mediated-drug resistance to sunitinib in HMEC-su cells by inhibiting PI3K/Akt signaling.
first_indexed 2024-04-12T20:42:11Z
format Article
id doaj.art-fe3b3d92e73f486ea566ab9308260298
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-04-12T20:42:11Z
publishDate 2022-09-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-fe3b3d92e73f486ea566ab93082602982022-12-22T03:17:23ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902022-09-015810.1590/s2175-97902022e191102Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathwayRong ZhangLimin Huanghttps://orcid.org/0000-0003-3053-0160Di PanWen ZhangAbstract Drug resistance is a crucial obstacle to achieve satisfactory chemotherapeutic effects. Numerous studies have shown that the PI3K/Akt signaling pathway plays a significant role in various processes of cellular events and tumor progression, while few studies have focused on the PI3K/Akt signaling pathway in drug resistance of endothelial cells. The present study aims to explore the relationship of PI3K/Akt signaling and cellular resistance to anticancer drugs in human microvessel endothelial cells (HMEC-1). We established stable sunitinib-resiatant human microvessel endothelial cells (HMEC-su) after long-term exposure to sunitinib (a small-molecule tyrosine kinase receptor inhibitor) for 12 months. HMEC-su showed significant alternations of cell morphology and exhibited a 2.32-fold higher IC50 of sunitinib than parental HMEC-1 cells. Expression of P-glycoprotein (P-gp) and breast cancer-resistance protein (ABCG2) which mediates drug efflux, increased significantly in HMEC-su lines compared with HMEC-1 cells by western blots assay. Our study further demonstrates that LY294002 (blocking the PI3K/Akt pathway) enhances the sensibility of HMEC-su to suntinib and inhibits the gene transcription and protein expression of P-gp, ABCG2 in HMEC-su cells. In conclusion, these results indicate that LY294002 could reverse P-gp and ABCG2 mediated-drug resistance to sunitinib in HMEC-su cells by inhibiting PI3K/Akt signaling.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100700&tlng=enDrug resistanceEndothelial cellsP-glycoproteinSunitinibPI3K/Akt pathway
spellingShingle Rong Zhang
Limin Huang
Di Pan
Wen Zhang
Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
Brazilian Journal of Pharmaceutical Sciences
Drug resistance
Endothelial cells
P-glycoprotein
Sunitinib
PI3K/Akt pathway
title Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
title_full Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
title_fullStr Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
title_full_unstemmed Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
title_short Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
title_sort sunitinib induced resistance of endothelial cells by up regulating p glycoprotein and pi3k akt pathway
topic Drug resistance
Endothelial cells
P-glycoprotein
Sunitinib
PI3K/Akt pathway
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100700&tlng=en
work_keys_str_mv AT rongzhang sunitinibinducedresistanceofendothelialcellsbyupregulatingpglycoproteinandpi3kaktpathway
AT liminhuang sunitinibinducedresistanceofendothelialcellsbyupregulatingpglycoproteinandpi3kaktpathway
AT dipan sunitinibinducedresistanceofendothelialcellsbyupregulatingpglycoproteinandpi3kaktpathway
AT wenzhang sunitinibinducedresistanceofendothelialcellsbyupregulatingpglycoproteinandpi3kaktpathway